Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.
Jacobsen K, Bertran-Alamillo J, Molina MA, Teixidó C, Karachaliou N, Pedersen MH, Castellví J, Garzón M, Codony-Servat C, Codony-Servat J, Giménez-Capitán A, Drozdowskyj A, Viteri S, Larsen MR, Lassen U, Felip E, Bivona TG, Ditzel HJ, Rosell R.
Jacobsen K, et al. Among authors: rosell r.
Nat Commun. 2017 Sep 4;8(1):410. doi: 10.1038/s41467-017-00450-6.
Nat Commun. 2017.
PMID: 28871105
Free PMC article.